Found: 13
Select item for more details and to access through your institution.
Crosstalk between CD64<sup>+</sup>MHCII<sup>+</sup> macrophages and CD4<sup>+</sup> T cells drives joint pathology during chikungunya.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 3, p. 641, doi. 10.1038/s44321-024-00028-y
- By:
- Publication type:
- Article
Acquired immunity against SARS‐CoV‐2 infection and vaccination.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 12, p. 1, doi. 10.15252/emmm.202216345
- By:
- Publication type:
- Article
Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 6, p. 1, doi. 10.15252/emmm.201810092
- By:
- Publication type:
- Article
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 1, p. 24, doi. 10.15252/emmm.201404459
- By:
- Publication type:
- Article
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.64909
- By:
- Publication type:
- Article
Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay.
- Published in:
- BMC Infectious Diseases, 2006, v. 6, n. 1, p. 40, doi. 10.1186/1471-2334-6-40
- By:
- Publication type:
- Article
Organ‐specific immune response in lethal SARS‐CoV‐2 infection by deep spatial phenotyping.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 5, p. 1, doi. 10.1002/cti2.1384
- By:
- Publication type:
- Article
Systematic analysis of disease‐specific immunological signatures in patients with febrile illness from Saudi Arabia.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 8, p. 1, doi. 10.1002/cti2.1163
- By:
- Publication type:
- Article
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 7, p. 1, doi. 10.1002/cti2.1160
- By:
- Publication type:
- Article
Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 7, p. 1, doi. 10.1002/cti2.1159
- By:
- Publication type:
- Article
Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 4, p. 1, doi. 10.1002/cti2.1126
- By:
- Publication type:
- Article
Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 2, p. 1, doi. 10.1002/cti2.1118
- By:
- Publication type:
- Article
Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients.
- Published in:
- Clinical & Translational Immunology, 2019, v. 8, n. 7, p. N.PAG, doi. 10.1002/cti2.1066
- By:
- Publication type:
- Article